The Procter & Gamble Company

The Procter & Gamble Company

PG
The Procter & Gamble CompanyUS flagNew York Stock Exchange
150.86
USD
+3.18
- -
351.29BMarket Cap
The Procter & Gamble Company
PG
(New York Stock Exchange)

Recent

price

150.86

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
26.31
28.92
29.12
28.61
26.77
25.14
23.61
24.62
26.42
25.18
27.94
30.27
32.64
33.97
34.91
35.19
36.47
Revenue per Share
4.25
4.12
3.73
3.95
4.1
2.41
3.71
5.71
3.75
1.35
5.03
5.58
5.89
5.95
6.06
6.55
6.86
Basic EPS, GAAP
5.47
4.75
4.72
5.31
5.02
5.19
5.58
4.83
5.88
5.67
6.85
7.31
6.81
6.98
8.24
7.44
8.16
Free Cash Flow per Basic Share
1.85
2.06
2.18
2.33
2.49
2.59
2.69
2.74
2.89
2.79
3.07
3.29
3.57
3.73
3.87
4.12
4.28
Dividend per Share
23.28
26.64
28.18
30.07
32.03
31.56
33.26
37.89
40.58
36.81
41.05
43.9
47.39
50.61
53.09
55.94
58.64
Book Value per Share
-8.64
-8.35
-7.79
-6.85
-5.64
-2.72
-4.31
-5.34
-6.78
-6.64
-6.97
-7.47
-7.07
-7.54
-5.23
-5.03
-3.75
Tangible Book Value per Share
2,948
2,804
2,816
2,800
2,779
2,814
2,765
2,642
2,529
2,688
2,539
2,514
2,457
2,414
2,408
2,395
2,378
Basic Weighted Avg Shares
77,567
81,104
82,006
80,116
74,401
70,749
65,299
65,058
66,832
67,684
70,950
76,118
80,187
82,006
84,039
84,284
86,718
Sales/Revenue/Turnover
20.28
19.11
17.82
17.63
18.7
18.48
20.58
21.16
19.99
20.44
22.14
23.63
22.21
22.11
23.66
24.26
23.24
Operating Margin (%)
3,108
2,838
3,204
2,982
3,141
3,134
3,078
2,820
2,834
2,824
3,013
2,735
2,807
2,714
2,896
2,847
3,071
Depreciation Expense
12,736
11,797
10,756
11,312
11,643
7,036
10,508
15,326
9,750
3,897
13,027
14,306
14,742
14,653
14,879
15,974
16,616
Net Income, GAAP
27.02
22
26.96
22.75
21.1
24.75
25
23.1
26
34.65
17.25
18.52
17.79
19.7
20.19
20.34
20.4
Effective Tax Rate (%)
16.42
14.55
13.12
14.12
15.65
9.95
16.09
23.56
14.59
5.76
18.36
18.79
18.38
17.87
17.7
18.95
19.16
Profit Margin (%)
-5,500
-5,323
-2,997
-6,047
-2,109
-144
3,012
-3,716
-4,917
-7,538
-4,989
-10,041
-11,428
-13,108
-8,918
-10,666
-10,248
Working Capital
21,360
22,033
21,080
19,111
19,811
18,327
18,945
18,038
20,863
20,395
24,189
23,730
23,443
24,973
25,935
25,696
23,852
LT Debt
61,439
68,001
64,035
68,709
69,976
63,050
57,983
55,778
52,883
47,579
46,878
46,654
46,854
47,065
50,558
52,284
54,731
Total Equity
11.98
12.59
10.94
11.17
10.59
9.82
11
11.97
11.48
11.13
16.13
17.95
18.32
17.86
18.86
18.74
17.98
Return on Invested Capital (%)
13.32
11.82
10.19
10.28
9.89
5.99
8.85
12.11
7.45
3.13
9.83
10.28
10.23
9.84
9.67
9.98
9.97
Return on Capital (%)
19.27
16.14
13.63
13.53
13.15
7.62
11.34
15.7
9.35
3.61
12.56
13.08
12.75
12.05
11.68
11.98
11.99
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
11,631
11,062
13,174
LT Borrowings
24,315
25,577
23,852
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
770
767
759
Shares Outstanding
2,337
2,324
2,329
Market Capitalization
366,497
341,349
343,435

Working Capital

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
27,118
26,588
27,987
Cash, Cash Equivalents & STI
11,171
10,825
12,306
Accounts Receivable, Net
6,487
6,279
6,322
Inventories
7,848
7,817
7,853
Total Current Liabilities
37,995
36,699
38,235
Payables & Accruals
26,365
25,636
25,061
ST Debt
11,631
11,062
13,174
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1.73%
2.25%
3.41%
Free Cash Flow
2.65%
0.98%
-10.22%
Net Income, GAAP
25.42%
4.23%
7.36%
Sales/Revenue/Turnover
1.84%
3.53%
0.29%
Total Cash Common Dividend
3.18%
4.96%
6.13%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
21,871
21,441
20,195
20,532
84,039
2025
21,737
21,882
19,776
20,889
84,284
2026
22,386
22,208
21,235
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.89
1.41
1.56
1.27
6.06
2025
1.62
1.91
1.55
1.48
6.55
2026
1.97
1.79
1.63
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.97
0.95
0.97
1.01
3.87
2025
1.02
1.02
1.02
1.07
4.12
2026
1.07
1.07
1.07
- -
- -
Business
The Procter & Gamble Company (P&G) manufactures and markets a broad portfolio of branded consumer goods focused on beauty, grooming, health care, fabric and home care, and baby, feminine and family care; its leading brands include Tide, Pampers, Gillette, Dawn, Pantene, Bounty, Crest, Always, Charmin, Febreze, Ariel, Oral-B, Olay, Head & Shoulders, Downy, Gain, Cascade, Vicks, SK-II, Old Spice, Safeguard, Secret, Native, Braun, Venus, Luvs, Tampax, Puffs, Pepto-Bismol, Metamucil, and Prilosec OTC. The company organizes its operations into five core segments: Beauty, encompassing hair care products such as Head & Shoulders, Pantene and Herbal Essences, skin care offerings like Olay and SK-II, and deodorants including Secret and Old Spice; Grooming, featuring razors and related products from Gillette, Venus and Braun; Health Care, which provides oral care via Crest and Oral-B alongside personal health items such as Vicks respiratory remedies, Pepto-Bismol digestive aids, Metamucil fiber supplements and Prilosec OTC heartburn relief; Fabric & Home Care, delivering laundry solutions like Ariel, Tide, Gain and Downy plus home cleaners including Cascade dishwasher detergent, Dawn dishwashing liquid, Febreze odor eliminators, Mr. Clean surface care and Swiffer multi-surface tools; and Baby, Feminine & Family Care, supplying diapers through Pampers and Luvs, feminine protection via Always, Always Discreet and Tampax, and paper products such as Bounty towels, Charmin toilet paper and Puffs tissues. Founded in 1837 and headquartered in Cincinnati, Ohio, P&G serves consumers in approximately 70 countries with 48 percent of sales generated in the United States and the balance internationally, while manufacturing most products domestically. Recent developments include a US$150 million expansion of its Iowa City Oral-B facility to localize production starting in 2027 and add 100 jobs, alongside major investments such as US$450 million for a Mason, Ohio research campus upgrade, US$180 million for St. Louis manufacturing capacity in Cascade, Mr. Clean, Swiffer and Febreze, and US$96 million for Louisiana fabric care lines; the company also launched the Always Pocket Flexfoam portable period care product in 2025, announced 7,000 non-manufacturing job reductions by mid-2027 to fund innovation amid tariff uncertainties, streamlined its SKU portfolio by eliminating low performers, expressed openness to consumer health acquisitions, and named Shailesh Jejurikar as incoming CEO effective 2026.

Company News

APIChatGPT
  • 67 With $1.5 Million. Here Are My 3 Defensive Anchors

  • Why Procter & Gamble (PG) Dipped More Than Broader Market Today

  • SpaceX Stock Is All Over the Place. 3 Dividend Stocks to Buy Instead That Will Let You Sleep Well at Night

  • P&G And Albertsons Are Turning The Grocery Aisle Into A Studio

  • Tide Already Dominates Detergent. Why Is P&G Pushing a New Version?

  • The Dividend Growth Path That Turns $500,000 Into a Six-Figure Income Stream

  • This Dividend Portfolio Pays More Than Social Security and a Part-Time Job Combined

  • The $1 Million Retirement Mistake: Counting Income You’ll Never Get to Spend

  • The Retirement Portfolio That Forks Over a $10,000 Check Every Month

  • Procter & Gamble vs. Colgate-Palmolive: One Dividend Giant Stands Above the Rest

  • If You Think The Market Will Ever Fall, Buy This

  • 3 Dividend Aristocrats: Buy, Sell or Hold?

  • The $1.5 Million Portfolio That Out-Earns the Median U.S. Household

  • The Dividend Growth Path That Turns $60,000 a Year Into $125,000

  • Align Probiotic Launches Nationwide Call For Backup to Help Women 50 and Beyond Combat Occasional Gas and Bloat

  • 3 Dividend Stocks That Pay You More Every Single Year

  • How to Build $5,000 a Month in Dividend Income and Never Touch Your Principal

  • Fidelity vs. State Street: Which Consumer Staples ETF Stands Out?

  • Procter & Gamble Scripted Dramas Are Coming to a Supermarket Near You

  • Procter & Gamble (PG) Advances While Market Declines: Some Information for Investors